These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4299475)

  • 1. [Derivatives of viomycin. I. Preparation and properties of viomycin nicotinate and isonicotinate].
    Sobiczewski W; Cieślak J; Waszkiewicz A; Chojnowski W
    Acta Pol Pharm; 1968; 25(4):403-5. PubMed ID: 4299475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1968; 25(4):407-10. PubMed ID: 4299476
    [No Abstract]   [Full Text] [Related]  

  • 3. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of some viomycinmethyltetracyclines].
    Sobiczewski W; Cendrowska H; Chojnowski W
    Acta Pol Pharm; 1969; 26(6):505-10. PubMed ID: 4314647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viomycin derivatives. IV. Preparation and properties of some penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1969; 26(1):29-32. PubMed ID: 4305691
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and evaluation of antibacterial activity of (R)-2-methylheptyl isonicotinate, a putative naturally occurring bioactive agent.
    Cao J; Adler B; Perlmutter P
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5025-7. PubMed ID: 26497285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [N 1-nicotinoyl and isonicotinoylpyrazoles].
    Bondavalli F; Longobardi M; Schenone P
    Farmaco Sci; 1975 May; 30(5):391-8. PubMed ID: 1175764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activity of nicotinic acid hydroxylase and pyrocatechase in chemosensitive mycobacteria and their chemoresistant variants].
    Lippelt CH; Bönicke R
    Zentralbl Bakteriol Orig; 1968; 209(1):62-71. PubMed ID: 4317775
    [No Abstract]   [Full Text] [Related]  

  • 10. [STUDIES ON THE ANTIBACTERIAL SPECTRUM AND DETERMINATION OF THE BIOLOGICAL ACTIVITY OF FLORIMYCIN (VIOMYCIN)].
    TEBIAKINA AE; BUIANOVSKAIA IS; CHAIKOVSKAIA SM; SHNEERSON AN
    Antibiotiki; 1963 Oct; 8():901-5. PubMed ID: 14136417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antitubercular agents. V. Thioamides of the ring-substituted isonicotinic acid derivatives].
    Palát K; Celadník M; Novácek L; Matusková E; Pavlas M
    Cesk Farm; 1965 Dec; 14(10):502-6. PubMed ID: 5863121
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of the synthesis of various thiol-pyridine-carboxylic acids].
    Delarge J
    J Pharm Belg; 1967; 22(7):257-63. PubMed ID: 5609379
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of viomycin resistance in core particles derived from 30S ribosomal subunits of Mycobacterium smegmatis.
    Yamada T
    Biken J; 1976 Sep; 19(3):129-31. PubMed ID: 189750
    [No Abstract]   [Full Text] [Related]  

  • 15. Catalytic hydrogenation of viomycin and capreomycin.
    Dyer JR; Carter JH; van Wyk PJ
    J Med Chem; 1971 Nov; 14(11):1120-1. PubMed ID: 4329900
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of taxonomic characteristics of highly active viomycin-producing mutants of Streptomyces griseus var. purpureus.
    Tyc M; Kadzikiewicz T
    Acta Microbiol Pol B; 1972; 4(4):217-26. PubMed ID: 4345459
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on anticoccidial agents. 12. Synthesis and anticoccidial activity of methyl-2(6)-nitro- and -3(5)-nitropyridinecarboxamides.
    Morisawa Y; Kataoka M; Sakamoto T; Nagahori H; Kitano N; Kusano K
    J Med Chem; 1978 Feb; 21(2):194-9. PubMed ID: 621714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthesis of di-beta-lysylcapreomycin IIA, a capreomycin analog effective against viomycin-resistant Mycobacterium.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1983 Feb; 36(2):197-9. PubMed ID: 6187721
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
    Engbaek HC; Vergmann B; Baess I
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(5):619-31. PubMed ID: 4322001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.